


























































Risk of Surgery for Congenital Heart Disease in the
dult: A Multicentered European Study
ladimiro L. Vida, MD, Hakan Berggren, MD, William J. Brawn, MD,
illem Daenen, MD, Duccio Di Carlo, MD, Roberto Di Donato, MD,
arald L. Lindberg, MD, Antonio F. Corno, MD, Jose Fragata, MD,
artin J. Elliott, MD, Viktor Hraska, MD, Lazlo Kiraly, MD,
rançois Lacour-Gayet, MD, Bohdan Maruszewski, MD, Jean Rubay, MD,
eikki Sairanen, MD, George Sarris, MD, Andreas Urban, MD,
arin Van Doorn, MD, Gerhard Ziemer, MD, and Giovanni Stellin, MD
ediatric Cardiac Surgery Unit, University of Padova, Padova, Italy; The Queen Silvia Children=s Hospital, Goteborg, Sweden;
irmingham Children’s Hospital, Birmingham, United Kingdom; Gasthuisberg Universitair Ziekenhuis, Leuven, Belgium;
spedale Pediatrico Bambino Gesu, Rome, Italy; Rikshospitalet, The National Hospital, Oslo, Norway; Centre Hospitalier
niversitaire Vaudois, Lausanne, Switzerland; Hospital de Santa Marta, Lisbon, Portugal; The Cardiac Unit, The Great Ormond
treet Hospital for Children, London, United Kingdom; Children’s Hospital, Bratislava, Slovakia; Gottsegen Gyorgy Orszagos
ardiologiai Intezet, Gyermeksziv Kozpont, Budapest, Hungary; Eppendorf University Hospital, Hamburg, Germany; The
hildren’s Memorial Health Institute, Warsaw, Poland; Cliniques Universitaires Saint-Luc, Brussels, Belgium; Hospital for
hildren and Adolescents, University of Helsinki, Helsinki, Finland; Onassis Cardiac Surgery Center, Athens, Greece; Deutsches
inderherzzentrum, St. Augustin, Germany; Yorkshire Heart Centre, Leeds General Infirmary, Leeds, United Kingdom; and














eBackground. Surgery for congenital heart disease
CHD) has changed considerably during the last three
ecades. The results of primary repair have steadily
mproved, to allow treating almost all patients within the
ediatric age; nonetheless an increasing population of
dult patients requires surgical treatment. The objective of
his study is to present the early surgical results of patients
ho require surgery for CHD in the adult population
ithin a multicentered European study population.
Methods. Data relative to the hospital course of 2,012
dult patients (age >18 years) who required surgical
reatment for CHD from January 1, 1997 through Decem-
er 31, 2004 were reviewed. Nineteen cardiothoracic
enters from 13 European countries contributed to the
ata collection.
Results. Mean age at surgery was 34.4  14.53 years.
ost of the operations were corrective procedures (1,509
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2007 by The Society of Thoracic Surgeons
ublished by Elsevier Inc3.1%) and palliative procedures (39 patients, 1.9%). Six
undred forty-nine patients (32.2%) required surgical
losure of an isolated ostium secundum atrial septal
efect. Overall hospital mortality was 2%. Preoperative
yanosis, arrhythmias, and NYHA class III-IV, proved
ignificant risk factors for hospital mortality. Follow-up
ata were available in 1,342 of 1,972 patients (68%) who
ere discharged home. Late deaths occurred in 6 patients
0.5%). Overall survival probability was 97% at 60
onths, which is higher for corrective procedures (98.2%)
f compared with reoperations (94.1%) and palliations
86.1%).
Conclusions. Surgical treatment of CHD in adult pa-
ients, in specialized cardiac units, proved quite safe, ben-
ficial, and low-risk.
(Ann Thorac Surg 2007;83:161–8)
© 2007 by The Society of Thoracic Surgeonsurgery for congenital heart disease (CHD) has
changed considerably during the last three decades.
he results of primary repair of CHD have steadily
mproved and allowed to treat almost all patients within
he pediatric age group. This was in part due to a more
idespread screening of asymptomatic patients and to the
ptimization of the results of early correction in neonates
nd infants. Nonetheless, an increasing population of adult
atients requires surgical treatment for CHD. This selected
ccepted for publication July 21, 2006.
ddress correpondence to Dr Stellin, Department of Cardiovascularroup of patients includes the following: (1) patients with
ecognized CHD who have survived into adult age without
ny surgical treatment and without developing an irrevers-
ble damage to their heart and lungs; (2) patients who are
andidates for correction after previous palliative proce-
ures; (3) adult patients who either require reoperations
ecause of late complications or residual defects; (4) pa-
ients who require additional palliative procedures or even
eart transplantation [1–4], and (5) patients with previously
ndetected CHD who remained asymptomatic during
hildhood. Ostium secundum atrial septal defects (ASD II)
rovide the best example of CHD within this last group of
atients [4–6]. The majority of the latter patients usually
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Ror several years and generally are referred for surgical
losure of the ASD II because of increasing symptoms not
ontrolled by medical therapy [7–9]. The objective of this
tudy is to present the early surgical results of patients who
equire surgery for CHD in the adult population within a
ulticentered European study population.
aterial and Methods
ata were reviewed retrospectively relative to the hospi-
able 1. Main “Basic Diagnoses” Total Number of Patients 
iagnosis Category n
eptal defects 895
ulmonary venous anomalies 108
ystemic venous anomalies 5
ight heart lesions 420
eft heart lesions 311
ingle ventricle 70
ransposition of the great arteries 73
ouble outlet right ventricle 16
horacic arteries and veins 101
lectrophysiology 5
iscellaneous 8
SD II  ostium secundum atrial septal defect; AV  atrioventricula
um; PA pulmonary atresia; PAPVC partial anomalous pulmona
otal anomalous pulmonary venous connections; TGA  transposition
efect.al course of adult patients (18 years) who required Aurgical treatment of CHD from January 1, 1997 through
ecember 31, 2004. Nineteen cardiothoracic centres from
3 European Countries contributed initially to the data
ollection.
Individual consent was not obtained by patients en-
olled in this study. However, this is a retrospective
tudy, patients are not identified, and the chairperson of
ach Ethics Committee approved to send their data with
he aim of publication. This study was undertaken under
he aegis of the European Congenital Heart Surgeons
12)
Diagnosis Type n













monary valve stenosis 27
tein’s tricuspid valve 27
stenosis/regurgitation non-Ebstein related 20
monary valve regurgitation 18
IVS 6
genital aortic valve stenosis 88
genital aortic valve stenosis  regurgitation 63
aortic fibrous stenosis 56
genital aortic valve regurgitation 50
genital mitral valve stenosis/regurgitation 37
er 17
gle right ventricle 58
gle left ventricle 12




committed VSD type 5
A type 1
mic aortic coarctation 69
onary artery anomalies 12
ent ductus arteriosus 10
cular ring 5
genital III degree AV block 5
diac tumor 3
er 5
AVSD  atrioventricular septal defects; IVS  interventricular sep-
ous connections; RVOT right ventricular outflow tract; TAPVC
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Reen published under the aegis of the European Congenital
eart Surgeons Associations (ECHSA) [10, 11], which also
ounded the “European Congenital Database” [12–14].
Cardiac rhythm, preoperative risk factors, extra-cardiac
nomalies, diagnoses leading to surgery, surgical proce-
able 2. Main Diagnoses Leading to Surgery Listed
ccording to the Operative Surgical Category
ain diagnoses leading to palliative procedure (n  39)
ingle ventricle 17 (53.1%)
OF-PA 10 (28.1%)
orrected TGA 6 (9.5%)
bstein’s tricuspid valve 2 (6.2%)
ther 4 (3.1%)
ain diagnoses leading to corrective procedures (n  1509)
solated ASD II 649 (43.0%)
ongenital AoV stenosis/regurgitation 162 (10.7%)
artial AVSD 98 (6.5%)
SD 96 (6.3%)
APVC 93 (6.1%)
oarctation of the aorta 54 (3.6%)
VOTO 52 (3.4%)
ubaortic stenosis 48 (3.2%)
ingle ventricle 38 (2.6%)
ongenital MV insufficiency/stenosis 37 (2.5%)
etralogy of Fallot 37 (2.5%)
bstein anomaly 19 (1.3%)
DA 10 (0.7%)
upravalvar aortic stenosis 6 (0.3%)
ther diagnoses leading to correctiona 94 (6.4%)
ain diagnoses leading to reoperation (n  464)
ulmonary valve insufficiency 119 (25.7%)
onduit failure 79 (17.0%)
VOTO 56 (12.1%)
oV insufficiency 25 (5.4%)
itral valve insufficiency/stenosis 21 (4.5%)
esidual VSD 19 (4.1%)
ubaortic stenosis 18 (3.9%)
ostoperative third degree AV block 16 (3.5%)
oV stenosis 14 (3.1%)
esidual coarctation of the aorta 11 (2.3%)
rosthetic valve failure 11 (2.3%)
ardiomyopathy 11 (2.3%)
triopulmonary connection failure 11 (2.3%)
ricuspid valve regurgitation 8 (1.7%)
bstructive pulmonary vascular disease 2 (0.4%)
ther diagnoses leading to reoperation 43 (9.4%)
Other diagnoses not listed in the table included diagnostic of single or
ew patients.
oV  aortic valve; ASD II  ostium secundum atrial septal defect;
VSD  atrioventricular septal defect; DORV  double outlet right
entricle; MAPCAs  main pulmonary artery collaterals from aorta;
V  mitral valve; PA  pulmonary atresia; PAPVC  partial
nomalous pulmonary venous connections; PDA  patent ductus
rteriosus; PV  pulmonary valve; RVOTO  right ventricle out-
ow tract obstruction; TGA  transposition of the great arteries;
OF  tetralogy of Fallot; VSD  ventricular septal defect.ures, and postoperative complications were identified rccording to the Pediatric European Database Classifica-
ion [12–14].
For the analysis, surgical procedures were divided into
hree categories, including the following: (1) palliative
rocedures; (2) corrective procedures; and (3) reopera-
ions. Palliative [15] procedures include all operations
erformed to improve the patient’s clinical status, without
eparation between the systemic and the pulmonary circu-
ations. Corrective procedures [15] are operations employed
o achieve an anatomical or physiologic correction with
eparation of the pulmonary from the systemic circulation.
ncluded in this group are also “Fontan-type” repair and
one and a half ventricle repair.” Finally, reoperations
efer to procedures performed after an initial correction.
Because patients requiring surgical closure of an iso-
ated ASD II represent a large group within our adult
opulation with CHDs, and because this operation car-
ies a low mortality and morbidity rate, additional anal-
sis was performed excluding the ASD II group, with the
im to better evaluate the impact of cardiac surgery on
his age group of patients.
Results are presented as mean and standard deviation
median and range were used if data were not normally
istributed). To assess if there was a statistical difference
etween the groups, data were analyzed with analysis of
ariance. A multiple comparison test (Tukey test) was
urther employed to assess statistical significance be-
ween groups. A Wilcoxon signed rank test was used to
ssess the change in NYHA status at follow-up of pa-
ients who were discharged from the hospital in compar-
son with their preoperative clinical status [16]. Level of
ignificance was set at a p value of 0.05 or less.
Overall survival probability, as well as survival proba-
ility for different surgical categories (palliative proce-
ures, corrective procedures, and reoperation), and for
atients requiring isolated ASD II closure in comparison
ith patients requiring surgical treatment for all other
atients were analyzed according to the Kaplan-Meier
ethod. Patients only who were discharged from the
ospital and were subsequently clinically followed were
ntered in the probability of survival analysis.
esults
wo thousand twelve patients (18 years of age) requir-
ng surgical treatment for CHD were included in this
tudy. Of the 2,012 patients, 1,005 were males (50%) and
,007 females (50%). Mean age at surgery was 34.4 14.53
ears. Preoperative diagnosis was achieved by echocar-
iography in 1,225 of the 2,012 patients (60.9%). Magnetic
esonance and computer tomography of the thorax were
one in addition to echocardiography as an adjunct in
47 patients (32.1%) and cardiac catheterization 399
atients (19.8%).
According to the preoperative clinical evaluation, 647
atients (32.1%) belonged to New York Heart Association
NYHA) class I, 908 in NYHA class II (45.1%), 384 in
YHA class III (19.1%), and 73 in NYHA class IV (3.7%).
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Rrrhythmias were present in the remaining 199 patients
9.9%) and included the following: (1) atrial fibrillation in
06 patients (53.3%); (2) III degree AV block in 44 patients
22.1%); (3) supraventricular tachycardia in 21 patients
10.6%); (4) atrial flutter in 15 patients (7.5%); and (5)
ther arrhythmias in 13 patients (6.5%). Twenty-two
atients had a previous pacemaker implantation.
Preoperative variables which are commonly associated
able 3. Main Surgical Procedures, Listed Within Their Resp





ain corrective procedures (n  1509):









Tetralogy of Fallot correction
Mitral valve replacement/plasty
Total cavopulmonary connection
Ebstein’s tricuspid valve plasty
PDA closure
Supravalvar aortic stenosis correction
Other correctionsa

















Other diagnoses or surgical treatments not listed in the table included
oV  aortic valve; ASD II  ostium secundum atrial septal d
avopulmonary shunt; DORV  double outlet right ventricle; M
alve; PA  pulmonary atresia; PAPVC  partial anomalous pu
ulmonary valve; RV-MPA  right ventricle-to-main pulmonary
ransposition of the great arteries; VSD  ventricular septal defect.o an increased hospital morbidity and mortality were rdentified in 397 patients (19.7%), being multiple in 150
atients (37.7%). Preoperative cyanosis (247 patients,
2.3%) (p  0.0001), preoperative arrhythmias (199 pa-
ients, 9.9%) (p  0.03), and preoperative NYHA class III
nd IV (0.0001) were the only causes linked to an
ncreased hospital mortality. The principal basic diagnoses
nd diagnoses leading to surgery according to surgical
ategory (ie, palliative procedures, corrective procedures, or
e Surgical Categories
n (%) Hospital mortality - n (%)
18 (46.9%) 2 (11.1%)
15 (37.4%) 1 (6.6%)
3 (9.5%) –
3 (6.2%) –
n (%) Hospital mortality - n (%)
49 (43.0%) 1 (0.2%)
11 (7.4%) 2 (1.8%)
98 (6.5%) –
96 (6.3%) 1 (1%)




48 (3.2%) 1 (2%)
37 (2.5%) 2 (5.4%)
37 (2.5%) –




94 (6.4%) 7 (7.4%)
n (%) Hospital mortality - n (%)
23 (26.5%) 4 (3.1%)
67 (14.4%) –
45 (9.8%) 1 (2.2%)
35 (7.6%) –





15 (3.2%) 7 (46%)
11 (2.3%) –
11 (2.3%) –
9 (2.0%) 1 (11%)
9 (2.0%) 1 (11%)
8 (1.7%) –
43 (9.4%) 3 (6.9%)
ostic of surgical groups of single or few patients.
AVSD  atrioventricular septal defect; BCPS  bidirectional
As  main pulmonary artery collaterals from aorta; MV  mitral
ary venous connections; PDA  patent ductus arteriosus; PV 
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Rable 3 are the main surgical procedures within their
espective surgical categories. One-fourth of the patients
528 of 2,012, 26.2%) required additional surgical proce-
ures: 504 for intracardiac anomalies (95.4 %) and 24 for
xtracardiac anomalies (4.6%). Intraoperative atrial abla-
ion was performed concomitantly in 42 patients (2%),
hile 3 patients required a positioning of an internal
ardiac defibrillator. A pacemaker implantation was nec-
ssary in 38 patients (1.9%).
Major postoperative complications occurred in 444
atients (22%). One hundred eighteen patients (5.9%)
resented multiple complications (Table 4). There were
0 hospital deaths (2%). The most common causes were
he following: (1) sepsis (13 patients, 32.5%); (2) low
ardiac output syndrome (12 patients, 30%); followed by
3) arrhythmia (7 patients, 17.5%); (4) perioperative




ow output syndrome 42
ericardial effusion requiring drainage 35
leural effusion 35
neumothorax 32
eoperation during same admission 29
echanical ventilation 7 days 25






eurological deficit persisting at discharge 19
enal failure 17
racheostomy 12
aryngeal nerve injury 8
ardiac arrest 6
hrenic nerve injury 6
ther postoperative complications 19
able 5. Surgical Categories
ariables Analyzed Palliative Procedures
umber of procedures 39 (1.9%)
ex M/F 20/19
ean age in years (SD) 29.48 (11.6)a,c
reoperative sinus rhythm 37 (94.9%)b
reoperative cyanosis 35 (89.7%)d
ostoperative complications 20 (51.6%)d
inus rhythm at discharge 34 (94.4%)
ean ICU stay/days (SD) 3.71 (4.4)c
ean hospital stay/days (SD) 14.17 (8.0)b
ospital mortality (%) 3 (7.7%)c
In each category in which the p value is significant, those values with dif
omparison (Tukey) test (p  0.05).CU  intensive care unit.leeding (5 patients, 12.5%); and (5) neurological events
3 patients, 7.5%). Mortality was lower for corrective
rocedures (1.2%) when compared with reoperations
4.4%) and with palliative procedures (7.7%)
At the time of hospital discharge, 92% of the survivors
ere in sinus rhythm (1,813 of 1,972 patients). Postoper-
tive arrhythmias were present in the remaining 159
atients (8%), of which 109 were untreated arrhythmias
nd 55 new-onset arrhythmias. They included atrial fi-
rillation in 76 patients (47.8%), third degree AV block in
4 patients (40.2%), atrial flutter in 7 patients (4.4%), and
ther arrhythmias in 12 patients (7.6%).
Regarding surgical categories, most of the procedures
ere corrective procedures (1,509 patients, 75%), fol-
owed by reoperations (464 patients, 23.1%), and pallia-
ive procedures (39 patients, 1.9%). Patients who under-
ent corrective procedures presented with a significantly
ower mortality rate (p 0.001) requiring also less time in
he intensive care unit (p  0.002) and a shorter total
ospital stay (p  0.0001) (Table 5).
Six hundred forty-nine patients underwent isolated
SD II closure (32.2%), while 1,363 patients (67.8%)
equired surgical treatment for all other CHD. Patients
ho underwent isolated ASD II closure had a less
omplicated postoperative course, requiring less time in
he intensive care unit (p  0.0001) and a shorter total
ospital stay (p  0.0001) with a hospital mortality of
.2%. Nonetheless, even after eliminating patients who
nderwent isolated ASD II closure, the overall mortality
f the remaining 1,324 patients was still low (2.9%).
Follow-up data were available in 1,342 of 1,972 patients
68%) who were discharged from the hospital. Fourteen
uropean centers provided us with follow-up data, which
as 91% completed. Five European centers could not
rovide follow-up data but only with operative data. In
hese centers, patients were referred for surgical treat-
ent and were later followed by the referring physician
f peripheral cardiologic units.
Late deaths occurred in 6 patients (0.5%), 2 of which
ere not cardiac-related. Reoperation was necessary in
2 of 1,342 patients (0.9%), within a mean time of 29.5 
Corrective Procedures Reoperations p Value
1509 (75%) 464 (23.1%)
778/731 207/257 0.03
36.21 (15.1)b 28.94 (10.7)c 0.0001
1383 (91.7%)b 393 (84.7%)c 0.0001
143 (9.5%)b 69 (14.9%)c 0.0001
312 (20.7%)b 111 (23.9%)c 0.0001
1377 (92.4%) 402 (90.3%) 0.33
2.31 (5.4)b 3.25 (5.6)b 0.002
10.54 (9.0)b 12.53 (9.7)c 0.0001
18 (1.2%)b 19 (4.1%)c 0.0001
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R2.56 months after hospital discharge. At a mean fol-
ow-up time of 18.5  15.1 months, 1,041 of 1,257 patients
77.7%) belonged to NYHA class I, 265 in NYHA class II
19.7%), 29 in NYHA class III (2.2%), and 6 in NYHA class
V (0.4%). There was a statistical significant change of the
YHA status (p 0.001) between the preoperative period
nd the last follow-up control (mean follow-up time of
8.5  15.1 months). The median change is a decrease of
ne category.
Survival probability according to Kaplan-Meier
howed an overall survival of 97% at 60 months (Fig 1).
ccording to surgical categories, survival probability at
0 months is higher for corrective procedures (98.2%) if
ompared with reoperations (94.1%) or palliative proce-
ures (86.1%) (Fig 2) (p  0.0001). Survival probability at
0 months after surgery for patients who required surgi-
al closure of an isolated ASD II was 99.1%. Excluding the
SD II group of patients, the survival at 60 months for all
ther patients requiring surgical treatment was 95.5%
Fig 3) (p  0.0001).
omment
his study aims to assess the risks of cardiac surgery for
HD in patients of age 18 years or greater, treated in 19
ig 1. Overall survival probability according to the Kaplan-Meier
unction with 95% confidence bands.
ig 2. Kaplan-Meier survival function by type of surgery
tpalliations, corrections, reoperations).ifferent cardiac units in Europe. The number of adult
atients with congenital heart disease, treated and un-
reated, has been growing steadily since the 1960s due to
he increasing optimization of surgical and medical treat-
ent. According to Webb [6] the number of adult pa-
ients with CHD will be roughly equal in the next few
ears to those in pediatric age.
Surgery for CHD in adults is mostly indicated to hope-
ully prolong the patient’s life expectancy and to improve
ifestyle. While the natural history of CHD in children is
easonably well known, the natural history of adult patients
ith CHD is less well documented [3, 5].
Patients with CHD who reach the adult age usually
emain in good or mildly decreased functional status for
everal years and are eventually referred to surgical
reatment because of increasing symptoms not controlled
y medical therapy [2, 17–20]. They are a selected group
f patients mainly composed by individuals who have
urvived into adult age without irreversible damage to
heir heart and lung, or with previously undetected CHD
ho remained asymptomatic during childhood, or who
equire reoperations because of late complications or
esidual defects, after initial surgical treatment in the
hildhood. Surgical outcome for these patients is satis-
actory if treatment is performed before irreversible dam-
ge has occurred to the heart and lungs [3, 17]. This
ssertion is supported by finding in this study, confirm-
ng also that a decreased functional status (NYHA class
II-IV) and exposure to prolonged cyanosis proved to be
ignificant risk factors for an operative mortality.
A palliative procedure was offered to an adult patient
ith complex CHD with the hope to at least temporarily
mprove the clinical condition. Although the palliative
perations in these kinds of patients did achieve a
ecrease on cyanosis at low risk (hospital mortality of
.7%), we have no long-term functional results of these
atients to allow definitive conclusions.
Reoperation after a previous corrective procedure also
arried a low hospital mortality (4.1%). This group in-
ludes patients with either a residual lesion after correc-
ig 3. Kaplan-Meier survival function by ostium secundum atrial
eptal defect (ASD II) versus surgery for all other congenital heart
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Rfter their initial correction, and including mainly con-
uit placement-change (190 of 464 patients, 41%), pulmo-
ary valve change (45 of 464 patients, 10%), and aortic
alve replacement (35 of 464 patients, 7.5%). The relative
ow percentage of reoperations (23.1%) among all surgi-
al procedures could be justified by the increasing num-
er of interventions in the catheterization laboratory
such as for atrial septal defect closure, radiofrequency
blation, pacemaker implantation, etc). As a consequence
he number of patients with a residual isolated ASD II
ould also be underestimated. In fact, many patients
ould probably have been referred for percutaneous
ranscatheter treatment after surgery and therefore not
ntered in our surgical database.
A follow-up analysis shows an overall survival proba-
ility of 97% at 60 months, which is higher for corrective
rocedures (98.2%) if compared with reoperations
94.1%) and palliations (86.1%). Survival probability of
atients requiring closure of an isolated ASD II is 99.1%
t 60 months. After excluding the ASD II patients, sur-
ival rate at 60 months for all other patients was still
5.5%.
The majority of these patients survived into adult age
18 years) in good functional status, considering that
7.2% of them was in preoperative NYHA class I or II. Our
ata suggest that an adult congenital patient is treated early
n his clinical presentation (NYHA class I-II), the hospital
utcome can be better when compared to that of patients
ho presented with worst functional status (NYHA class
II-IV) with a significant increase in functional status at
idterm survival: 1,306 of 1,342 patients (97.4%) who were
ischarged from the hospital were in NYHA class I-II at the
8.5  15.1 months last follow-up control (p  0.001).
Obviously, long-term postoperative functional results
f these patients are extremely important to know, un-
ortunately we were able to collect follow-up information
nly in 68% of the patients and limited to 60 months after
he operations (mean of 18.5  15.1 months). The main
eason for this limitation of this study was that most of
he patients were referred to the tertiary centers for
urgical treatment and were later followed by the refer-
ing physician of peripheral cardiologic units. According
o that, believing that tertiary units have the duty to find
ut what happens to the patients referred to them for
urgery, we are now developing an educational program
ith the aim to involve peripheral unit in our data
ollection.
According to our data, surgical treatment of CHD in
dults when performed in specialized European cardiac
acilities, proved to be quite safe, beneficial, and low risk.
e believe that a 2% hospital mortality in our study
opulation compared well with the 5% mortality rate
rom the European Congenital Database [19–25]. It is
bvious that in the adult population we do not encounter
ery complex CHD; ie, hypoplastic left heart syndrome,
omplex functional single ventricle malformations, het-
rotaxia syndrome, etc.
The low mortality for adult patients who require sur-
ery for CHD, when compared with the pediatric popu-
ation, may be attributable to the high level of specializa-ion coming from the pediatric cardiac units participating
n the study. In fact, the care of adult patients with
orrected or uncorrected CHD is growing and already is
challenging new field in cardiology. It requires knowl-
dge of the following: (1) pathology of congenital cardiac
alformations; (2) treatment options (ie, surgery versus
nterventional cardiology; (3) postoperative cardiac and
oncardiac complications and sequelae; (4) acquired car-
iac and noncardiac diseases that appear with age; and
ventually, according to the high incidence of preoperative
nd postoperative arrhythmias (5) the need for expertise
n electophysiology [3, 17, 18]. To address the many
ifferent needs of this complex and growing patient
opulation, and in order to have a good outcome, this
omplex group of patients with CHD should be ad-
ressed to these units, and also new specialized units are
eeded around the world [26–27].
Furthermore, while a risk-adjusted method for surgery
f acquired heart diseases and surgical treatment of
ediatric patients with congenital heart disease have
een well established and refined over the last 10 years,
28–31], a risk-adjusted model to predict in-hospital mor-
ality for adult patients with CHD is still lacking. This will
e of fundamental importance to allow a meaningful
omparison and to evaluate surgical risks of this emerg-
ng group of patients.
e thank Dr Aldo Castañeda for reviewing our manuscript. This
ork has been undertaken under the aegis of the European
ongenital Heart Surgeons Association (ECHSA).
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